The neonatal exposure to general anesthetics has been associated with neuronal apoptosis and dendritic spines morphologic changes in the developing brain. Ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, is widely used in pediatric patients to induce general anesthesia, analgesia, and perioperative sedation. In the present study, we investigated short- and long-term effects of a single ketamine (20 mg/kg, s.c.) neonatal exposure at postnatal day 7 in rats on the hippocampal and frontal cortical cellular viability. Additionally, putative neurochemical alterations and neurobehavioral impairments were evaluated in the adulthood. Ketamine neonatal administration selectively decreased cellular viability in the hippocampus, but not in the frontal cortex, 24 h after the treatment. Interestingly, a single ketamine neonatal exposure prevented the vulnerability to glutamate-induced neurotoxicity in the frontal cortex of adult rats. No short- or long-term damage to cellular membranes, as an indicative of cell death, was observed in hippocampal or cortical slices. However, ketamine induced a long-term increase in hippocampal glutamate uptake. Regarding behavioral analysis, neonatal ketamine exposure did not alter locomotor activity and anxiety-related parameters evaluated in the open-field test. However, ketamine administration disrupted the hippocampal-dependent object recognition ability of adult rats, while improved the motor coordination addressed on the rotarod. These findings indicate that a single neonatal ketamine exposure induces a short-term reduction in the hippocampal, but not in cortical, cellular viability, and long-term alterations in hippocampal glutamate transport, improvement on motor performance, and short-term recognition memory impairment.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Abe H, Ishida Y, Iwasaki T (2004) Perirhinal N-methyl-D-aspartate and muscarinic systems participate in object recognition in rats. Neurosci Lett 356:191–194. https://doi.org/10.1016/j.neulet.2003.11.049
Bolles RC, Woods PJ (1964) The ontogeny of behaviour in the albino rat. Anim Behav 12:427–441. https://doi.org/10.1016/0003-3472(64)90062-4
Briner A, De Roo M, Dayer A, Muller D, Habre W et al (2010) Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology 112:546–556. https://doi.org/10.1097/ALN.0b013e3181cd7942
Chen WA, Parnell SE, West JR (1999) Early postnatal alcohol exposure produced long-term deficits in brain weight, but not the number of neurons in the locus coeruleus. Dev Brain Res 118:33–38. https://doi.org/10.1016/S0165-3806(99)00128-5
Constantino LC, Tasca CI, Boeck CR (2014) The role of NMDA receptors in the development of brain resistance through pre- and postconditioning. Aging Dis 5:430–441. https://doi.org/10.14336/AD.2014.0500430
Dal-Cim T, Ludka FK, Martins WC, Reginato C, Parada E, Egea J, López MG, Tasca CI (2013) Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J Neurochem 126:437–450. https://doi.org/10.1111/jnc.12324
Davidson AJ (2011) Anesthesia and neurotoxicity to the developing brain: the clinical relevance. Paediatr Anaesth 21:716–721. https://doi.org/10.1111/j.1460-9592.2010.03506.x
Dumas TC (2005) Developmental regulation of cognitive abilities: modified composition of a molecular switch turns on associative learning. Prog Neurobiol 76:189–211. https://doi.org/10.1016/j.pneurobio.2005.08.002
Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, Sprung J, Weaver AL, Schroeder DR, Warner DO (2011) Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 128:e1053–e1061. https://doi.org/10.1542/peds.2011-0351
Fredriksson A, Archer T (2003) Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine. Neurotox Res 5:549–564
Fredriksson A, Archer T (2004) Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotox Res 6:435–456
Gambrill AC, Barria A (2011) NMDA receptor subunit composition controls synaptogenesis and synapse stabilization. Proc Natl Acad Sci U S A 108:5855–5860. https://doi.org/10.1073/pnas.1012676108
Hamon B, Heinemann U (1988) Developmental changes in neuronal sensitivity to excitatory amino acids in area CA1 of the rat hippocampus. Brain Res 466:286–290
Hestrin S (1992) Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature 357:686–689. https://doi.org/10.1038/357686a0
Huang L, Liu Y, Jin W, Ji X, Dong Z (2012) Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCgamma-ERK signaling pathway in the developing brain. Brain Res 1476:164–171. https://doi.org/10.1016/j.brainres.2012.07.059
Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J et al (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70–74. https://doi.org/10.1126/science.283.5398.70
Ing C, DiMaggio C, Whitehouse A, Hegarty MK, Brady J, von Ungern-Sternberg BS, Davidson A, Wood AJJ, Li G, Sun LS (2012) Long-term differences in language and cognitive function after childhood exposure to anesthesia. Pediatrics 130:e476–e485. https://doi.org/10.1542/peds.2011-3822
Janoff A (1964) Alterations in lysosomes (intracellular enzymes) during shock; effects of preconditioning (tolerance) and protective drugs. Int Anesthesiol Clin 2:251–269
Jevtovic-Todorovic V, Absalom AR, Blomgren K, Brambrink A, Crosby G, Culley DJ, Fiskum G, Giffard RG, Herold KF, Loepke AW, Ma D, Orser BA, Planel E, Slikker W Jr, Soriano SG, Stratmann G, Vutskits L, Xie Z, Hemmings HC Jr (2013) Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg seminar. Br J Anaesth 111:143–151. https://doi.org/10.1093/bja/aet177
Jiang C, Wan X, Jankovic J, Christian ST, Pristupa ZB, Niznik HB, Sundsmo JS, le W (2004) Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease. Clin Neuropharmacol 27:63–73
Kalkman CJ, Peelen L, Moons KG, Veenhuizen M, Bruens M, Sinnema G, de Jong TP (2009) Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology 110:805–812. https://doi.org/10.1097/ALN.0b013e31819c7124
Lecointre M, Vezier C, Benard M, Ramdani Y, Dupre N et al (2015) Age-dependent alterations of the NMDA receptor developmental profile and adult behavior in postnatally ketamine-treated mice. Dev Neurobiol 75:315–333. https://doi.org/10.1002/dneu.22232
Lisek M, Ferenc B, Studzian M, Pulaski L, Guo F, Zylinska L, Boczek T (2017) Glutamate deregulation in ketamine-induced psychosis-a potential role of PSD95, NMDA receptor and PMCA interaction. Front Cell Neurosci 11:181. https://doi.org/10.3389/fncel.2017.00181
Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci 27:2846–2857. https://doi.org/10.1523/JNEUROSCI.0116-07.2007
Liu F, Paule MG, Ali S, Wang C (2011) Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Curr Neuropharmacol 9:256–261. https://doi.org/10.2174/157015911795017155
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Ludka FK, Dal-Cim T, Binder LB, Constantino LC, Massari C, Tasca CI (2016) Atorvastatin and fluoxetine prevent oxidative stress and mitochondrial dysfunction evoked by glutamate toxicity in hippocampal slices. Mol Neurobiol 54:3149–3161. https://doi.org/10.1007/s12035-016-9882-6
Molz S, Dal-Cim T, Tasca CI (2009) Guanosine-5′-monophosphate induces cell death in rat hippocampal slices via ionotropic glutamate receptors activation and glutamate uptake inhibition. Neurochem Int 55:703–709. https://doi.org/10.1016/j.neuint.2009.06.015
Molz S, Dal-Cim T, Budni J, Martin-de-Saavedra MD, Egea J et al (2011) Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3beta pathway activation and inducible nitric oxide synthase inhibition. J Neurosci Res 89:1400–1408. https://doi.org/10.1002/jnr.22681
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63. https://doi.org/10.1016/0022-1759(83)90303-4
Olney JW, Farber NB, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C (2000) Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect 108(Suppl 3):383–388
Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14:383–400. https://doi.org/10.1038/nrn3504
Paule MG, Li M, Allen RR, Liu F, Zou X, Hotchkiss C, Hanig JP, Patterson TA, Slikker W Jr, Wang C (2011) Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol 33:220–230. https://doi.org/10.1016/j.ntt.2011.01.001
Piermartiri TC, Vandresen-Filho S, de Araujo Herculano B, Martins WC, Dal'agnolo D et al (2009) Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake. Neurotox Res 16:106–115. https://doi.org/10.1007/s12640-009-9057-6
Rhodes JS, Garland T Jr, Gammie SC (2003) Patterns of brain activity associated with variation in voluntary wheel-running behavior. Behav Neurosci 117:1243–1256. https://doi.org/10.1037/0735-7044.117.6.1243
Rice D, Barone S Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(Suppl 3):511–533
Robinson MB, Jackson JG (2016) Astroglial glutamate transporters coordinate excitatory signaling and brain energetics. Neurochem Int 98:56–71. https://doi.org/10.1016/j.neuint.2016.03.014
Soriano SG, Liu Q, Li J, Liu JR, Han XH, Kanter JL, Bajic D, Ibla JC (2010) Ketamine activates cell cycle signaling and apoptosis in the neonatal rat brain. Anesthesiology 112:1155–1163. https://doi.org/10.1097/ALN.0b013e3181d3e0c2
Sprung J, Flick RP, Katusic SK, Colligan RC, Barbaresi WJ, Bojanić K, Welch TL, Olson MD, Hanson AC, Schroeder DR, Wilder RT, Warner DO (2012) Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia. Mayo Clin Proc 87:120–129. https://doi.org/10.1016/j.mayocp.2011.11.008
Sun L (2010) Early childhood general anaesthesia exposure and neurocognitive development. Br J Anaesth 105(Suppl 1):i61–i68. https://doi.org/10.1093/bja/aeq302
Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83:482–504. https://doi.org/10.1037//0033-2909.83.3.482
Wang C (2012) Advanced pre-clinical research approaches and models to studying pediatric anesthetic neurotoxicity. Front Neurol 3:142. https://doi.org/10.3389/fneur.2012.00142
Yan J, Jiang H (2014) Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain. J Neurosurg Anesthesiol 26:155–160. https://doi.org/10.1097/ANA.0000000000000027
Yon JH, Daniel-Johnson J, Carter LB, Jevtovic-Todorovic V (2005) Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 135:815–827. https://doi.org/10.1016/j.neuroscience.2005.03.064
Young C, Jevtovic-Todorovic V, Qin YQ, Tenkova T, Wang H, Labruyere J, Olney JW (2005) Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 146:189–197. https://doi.org/10.1038/sj.bjp.0706301
Yuan T, Bellone C (2013) Glutamatergic receptors at developing synapses: the role of GluN3A-containing NMDA receptors and GluA2-lacking AMPA receptors. Eur J Pharmacol 719:107–111. https://doi.org/10.1016/j.ejphar.2013.04.056
Zhao T, Li C, Wei W, Zhang H, Ma D, Song X, Zhou L (2016) Prenatal ketamine exposure causes abnormal development of prefrontal cortex in rat. Sci Rep 6:26865. https://doi.org/10.1038/srep26865
Zou X, Patterson TA, Sadovova N, Twaddle NC, Doerge DR, Zhang X, Fu X, Hanig JP, Paule MG, Slikker W, Wang C (2009) Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci 108:149–158. https://doi.org/10.1093/toxsci/kfn270
This research was supported by grants from Brazilian funding agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq #307319/2012-1), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/PVE 052/2012; CAPES-FCT 2014), Programa de Apoio aos Núcleos de Excelência (PRONEX-Project NENASC), Fundação de Apoio à Pesquisa do Estado de Santa Catarina (FAPESC), Instituto Nacional de Ciência e Tecnologia (INCT for Excitotoxicity and Neuroprotection); and by Portuguese funding agencies Fundação para a Ciência e Tecnologia (FCT, Portugal) (Strategic Project 2015-UID/NEU/04539/2013), COMPETE-FEDER (POCI-01-0145-FEDER-007400), Centro 2020 Regional Operational Programmes (CENTRO-01-0145-FEDER-000012: HealthyAging 2020 and CENTRO-01-0145-FEDER-000008: BrainHealth 2020). C.I.T. and R.D.P. are recipient of research fellowship from CNPq.
Conflict of Interest
The authors declare that they have no conflicts of interest.
About this article
Cite this article
Sampaio, T.B., de Oliveira, L.F., Constantino, L.C. et al. Long-Term Neurobehavioral Consequences of a Single Ketamine Neonatal Exposure in Rats: Effects on Cellular Viability and Glutamate Transport in Frontal Cortex and Hippocampus. Neurotox Res 34, 649–659 (2018). https://doi.org/10.1007/s12640-018-9927-x
- Glutamatergic neurotransmission
- Locomotor activity